Your gut microbiome is a biological factory, and no two work exactly alike

Jacques Mathieu, PhD | August 1, 2026

Two groups of mice had the same genes, ate the same food, and lived in the same laboratory. The only difference was that their guts had been populated by different bacterial communities. One group received gut microbes from a lean human twin. The other received microbes from that twin's sibling, who had obesity.

Within 15 days, the mice that received the obesity-associated microbiome increased their fat mass by roughly 10%, while the lean-microbiome group showed little change. Under a diet lower in saturated fat and richer in fruits and vegetables, microbes from the lean group could also spread to the other mice and prevent much of the effect.¹

The microbial community was not merely a consequence of obesity. It carried the trait from one host to another. Change the community, and you change what the body does with the same inputs. Same food. Same setting. Different output.

The microbiome is not the only driver of body weight, but it is an active part of the system, and its influence reaches well beyond weight. Gut microbes transform food into chemicals, alter medications, and change compounds the body makes itself. Because each person carries a different community, the same meal, pill, or supplement may not produce the same result in everyone. You have probably noticed this without having a name for it: the friend who eats whatever they want, the supplement that did nothing for you but your friend swears by, the medication that hit you harder than it hit someone else.

Your gut is not simply a tube that digests food. It is a biological factory. And the factory inside you is not identical to anyone else's.

The Factory Inside You

The digestive tract contains bacteria, fungi, viruses, and other microorganisms. Together with their genes, products, and interactions, they form the gut microbiome. Large human studies have shown that even healthy people can carry very different microbial communities.² There is no universal healthy or unhealthy microbiome.

In essence, the gut microbiome is a factory. A factory has raw materials, machinery, production lines, and outputs. Your gut microbiome has these as well.

The raw materials are fibers and resistant starches that human enzymes cannot fully break down, along with amino acids from protein, plant compounds, bile acids, mucus, medications, and supplements. The machinery is the set of enzymes encoded by microbial genes. The production lines are the reactions those enzymes perform, often with one microbe using what another made.

The outputs are metabolites: small chemicals made, used, or changed during metabolism. Some act inside the gut. Others cross the intestinal wall into the blood.

How much does that matter? Mice raised with and without gut microbes differ in hundreds of blood chemicals.³ Estimates in people vary by method. One study linked microbial pathways to 15% of 673 blood metabolites.⁴ Another associated the microbiome with about 44% of 930 measured blood metabolites.⁵ A large share of what circulates in your blood is produced by the factory in your gut, and yours is unique.

What Goes Into the Factory?

Most digestible carbohydrates, fats, and proteins are absorbed in the small intestine. What remains reaches the colon, where the largest microbial community in the digestive tract lives: mostly fiber and resistant starch, with smaller amounts of protein and plant compounds.

The body also provides inputs to the factory. It releases bile acids to digest fat, produces mucus that coats the gut wall, sheds cells, and sends drugs through the intestine. Gut microbes can use, modify, or recycle much of it.

Diet matters a lot, but diet is only the input. The output depends on which organisms are present and which production lines are running.

What Comes Out of the Factory?

The factory produces a changing mixture, not one uniform output. Some products nourish the body. Some are neutral. Others turn harmful in excess, in the wrong place, or when the body cannot clear them.

The Same Meal, Different Blood Sugar

Researchers tracked nearly 47,000 meals eaten by 800 people using continuous glucose monitors. The same food often caused very different blood sugar changes. By adding microbiome data and basic health information, the researchers could better predict which foods would raise each person's blood sugar than they could by simply counting carbohydrates.⁶

General nutrition advice is still useful. It just cannot describe any particular person's response.

Fiber Can Become Fuel

Some microbes ferment fiber into short-chain fatty acids, including acetate, propionate, and butyrate. Butyrate is especially important. It is a major fuel for the cells lining the colon, helps keep the large intestine low in oxygen, and supports the barrier between gut and bloodstream. In germ-free mice (mice without a gut microbiome), colon cells had less energy; supplying butyrate restored much of that deficit.^7,8

But not every type of fiber yields the same amount of butyrate in every person. Different microbes prefer different fibers, and many production lines need several species working together.

How Much Energy You Recover Can Vary

Microbial fermentation also changes how much energy the body recovers from food. In one study, participants ate a diet designed to deliver more food to the colon. Yet the energy left unabsorbed varied from about 73 to 390 calories per day, a range of more than fivefold. Microbial biomass and fermentation products were strongly linked to that variation.⁹

That is a spread of more than 300 calories a day from identical food. It does not make the microbiome the sole cause of weight gain or loss, but it is one concrete route from the opening experiment to a difference between two people.

Food Can Feed Less Helpful Pathways

Many gut bacteria make small amounts of p-cresol from tyrosine, an amino acid in protein, but high-level production is concentrated in a handful of species. Of 153 gut bacteria studied, 55 made at least some p-cresol, and only four were high producers: Blautia hydrogenotrophica, Clostridioides difficile, Romboutsia lituseburensis, and Olsenella uli.¹⁰ Across the stool datasets HelloTummy has reviewed, the share of people carrying each ranged from roughly 1% to about 50%. Whether you happen to carry one of them can substantially change how much p-cresol you make.

Once absorbed, most of it becomes p-cresyl sulfate, which circulates in the blood and is normally cleared by the kidneys.¹¹ At high concentrations, p-cresol damages human colon cells and the lining of blood vessels.^12,13 When clearance falters, with age or with kidney disease, p-cresyl sulfate accumulates, and higher levels have been associated with faster kidney decline.¹⁴

Serum p-cresol also runs about five times higher in elderly populations, although centenarians with “youthful” microbiomes whose kidney function had not declined showed no such rise.¹⁵ However, even in people whose kidneys work normally, higher blood p-cresyl sulfate has been associated with all-cause mortality, and together with indoxyl sulfate it helped predict five-year mortality risk.¹⁶ None of this makes protein good or bad. The same amino acid enters different production lines in different people, and the output depends on which microbes are present and how well the body clears the result.

The Factory Can Remove Compounds

Microbes do not only make chemicals. They also consume them. Oxalate is a compound found in many ordinary foods, including spinach, rhubarb, beets, nuts, and tea. Human enzymes cannot break it down. Once it is absorbed, it passes into the urine, where it can bind to calcium and form crystals.

Those crystals are the everyday kind of kidney stone. Calcium oxalate accounts for the large majority of all stones, and stones are common: roughly 5 to 15 percent of people in the United States form one at some point, and between a third and a half of them form another within five years.

Oxalobacter formigenes uses oxalate as its main energy source, consuming it in the colon before the body can absorb it. In one study, having this bacteria was associated with about 70% lower odds of being a recurrent kidney stone former.¹⁷ A compound may be absorbed, transformed into something else, or consumed by your gut microbiome, preventing it from escaping your gastrointestinal tract – for better or for worse.

The Factory Can Change Medications

Some gut bacteria can inactivate medication or drugs you take, activate them, or change how much reaches the bloodstream. The cancer drug irinotecan is a striking example. The liver adds a chemical tag that marks the active drug for removal. Bacterial enzymes strip that tag off inside the intestine and reactivate the drug, which can worsen severe diarrhea.¹⁸

Digoxin, a heart medication, can be inactivated by Eggerthella lenta before the body absorbs it. But not every E. lenta strain can do this. The ability depends on specific genes, and experimental work found that diet could change how active those genes were.¹⁹

These examples show why a species name is useful but not the whole story. The strain, its genes, the surrounding community, and the available diet can all affect the output.

Why Two Factories Stay Different

Each person begins with a different collection of species and strains. The community is shaped by age, diet, medications, illness, environment, and earlier exposures. It can change over time, but it is not rebuilt from scratch after every meal.

The Microbiome is a Network

Microbes trade nutrients and products. One species may release a compound that another species needs, while a third may remove a waste product that would otherwise slow the process. The output comes from the network, not from each organism acting alone.

That network structure is part of why two people stay different. Some organisms have an outsized effect on the wider community, well beyond their share of the population. Ecologists call these keystone species. The term is still being refined for the human gut, but the idea is important: abundance is not the same as importance.

Faecalibacterium prausnitzii is one example. It is a major butyrate producer in many adults and is often less abundant in people with intestinal disorders and other health conditions. Its presence does not prove a microbiome or person is healthy, but losing an organism with a central role can change how the whole network functions.²⁰

The Factory Can Change, but It Also Remembers

A gut community can respond quickly. In a controlled feeding study, animal-based and plant-based diets shifted the microbiome within days. Two days after the animal-based diet ended, the community had already moved back toward its original structure.²¹

Longer studies show the other side of that stability. On average, about 60% of bacterial strains remained in the same person over five years, and many appeared likely to persist for decades.²² A short intervention may therefore create a temporary shift, while lasting change may require continued pressure.

The same individuality explains why people differ in immune signaling, resistance to pathogens, and whether a probiotic can stay in the gut.^23-25 Each deserves its own article. The principle is the same: different networks, different biology.

Why Measurement Matters

A microbiome test cannot predict every response. What it can do is show where you started and whether the community changed after you changed something.

Personalization does not begin with a perfect recommendation. It begins with observation.

Sequencing a stool sample gives a detailed inventory of the bacteria in your lower gut and an estimate of their relative abundance, meaning each one's share of the community rather than a head count. Stool is a practical, repeatable measure of the colonic community.²⁶ Full-length 16S rRNA sequencing reads nearly the entire marker gene used to identify bacteria and can resolve many to the species level.²⁷ That is a lot of information from one non-invasive sample.

In factory terms, sequencing is an inventory of equipment and workers, not a production report. It does not measure which genes are active or how much butyrate or p-cresol is being made. But an inventory tells you which production lines might be running, what is worth testing, and how the factory floor changes over time.

The value comes from comparison. A single sample describes one moment. It cannot show whether anything you did changed it.

That leads to a simple process:

1.         Take a baseline sample before making the change.

2.         Change one defined variable, such as a fiber supplement, diet pattern, or probiotic.

3.         Track the outcome you actually care about.

4.         Test again after enough time has passed to look for a meaningful change.

Even a flat result is useful: it says the community resisted the change. A shift shows which parts moved. Either way, an invisible process becomes an observable one. One sample is a snapshot. Two show direction.

HelloTummy's Point of View

At HelloTummy, we do not believe something as complex as the gut microbiome can be reduced to a single wellness score.

A microbiome test will not tell you everything, and it should never be presented as a diagnosis. But it can give you something most gut health advice cannot: a starting point from your own biology.

The future of gut health will not be built on one ideal microbiome or one set of recommendations for everyone. It will be built by learning how different factories respond to the same inputs, and turning those differences into better decisions.

 

Establish your baseline →

References

1. Ridaura, V. K. et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341, 1241214 (2013).

2. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 486, 207-214 (2012).

3. Wikoff, W. R. et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc. Natl Acad. Sci. USA 106, 3698-3703 (2009).

4. Visconti, A. et al. Interplay between the human gut microbiome and host metabolism. Nat. Commun. 10, 4505 (2019).

5. Diener, C. et al. Genome-microbiome interplay provides insight into the determinants of the human blood metabolome. Nat. Metab. 4, 1560-1572 (2022).

6. Zeevi, D. et al. Personalized nutrition by prediction of glycemic responses. Cell 163, 1079-1094 (2015).

7. Donohoe, D. R. et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab. 13, 517-526 (2011).

8. Kelly, C. J. et al. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe 17, 662-671 (2015).

9. Corbin, K. D. et al. Host-diet-gut microbiome interactions influence human energy balance: a randomized clinical trial. Nat. Commun. 14, 3161 (2023).

10. Saito, Y., Sato, T., Nomoto, K. & Tsuji, H. Identification of phenol- and p-cresol-producing intestinal bacteria by using media supplemented with tyrosine and its metabolites. FEMS Microbiol. Ecol. 94, fiy125 (2018).

11. Dodd, D. et al. A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature 551, 648-652 (2017).

12. Andriamihaja, M. et al. The deleterious metabolic and genotoxic effects of the bacterial metabolite p-cresol on colonic epithelial cells. Free Radic. Biol. Med. 85, 219-227 (2015).

13. Mankhong, S. et al. The microbial metabolite p-cresol compromises the vascular barrier and induces endothelial cytotoxicity and inflammation in a 3D human vessel-on-a-chip. Sci. Rep. 14, 18553 (2024).

14. Wu, I. W. et al. p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease. Nephrol. Dial. Transplant. 26, 938-947 (2011).

15. Sun, L. et al. Age-dependent changes in the gut microbiota and serum metabolome correlate with renal function and human aging. Aging Cell 22, e14028 (2023).

16. Nemet, I. et al. Microbe-derived uremic solutes enhance thrombosis potential in the host. mBio 14, e01331-23 (2023).

17. Kaufman, D. W. et al. Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J. Am. Soc. Nephrol. 19, 1197-1203 (2008).

18. Wallace, B. D. et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 330, 831-835 (2010).

19. Haiser, H. J. et al. Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta. Science 341, 295-298 (2013).

20. Lopez-Siles, M. et al. Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. ISME J. 11, 841-852 (2017).

21. David, L. A. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559-563 (2014).

22. Faith, J. J. et al. The long-term stability of the human gut microbiota. Science 341, 1237439 (2013).

23. Wastyk, H. C. et al. Gut-microbiota-targeted diets modulate human immune status. Cell 184, 4137-4153.e14 (2021).

24. Buffie, C. G. et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517, 205-208 (2015).

25. Maldonado-Gómez, M. X. et al. Stable engraftment of Bifidobacterium longum AH1206 in the human gut depends on individualized features of the resident microbiome. Cell Host Microbe 20, 515-526 (2016).

26. Rode, J. et al. Fecal samples and rectal swabs adequately reflect the human colonic luminal microbiota. Gut Microbes 16, 2416912 (2024).

27. Johnson, J. S. et al. Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis. Nat. Commun. 10, 5029 (2019).